Targeting insomnia to help adults who use cannabis
Official title: Targeting insomnia to improve outcomes in adults with problematic cannabis use
Funded at University of Michigan at Ann Arbor · NIH-11359689 · Data updated 2026-11-12
We’re testing a sleep-focused treatment to help adults with heavy cannabis use reduce sleep problems and cannabis use.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project start | September 15, 2022 |
| Project end | July 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $654,709 |
| NIH project number | 5R01DA057297-05 |
| Project ID | NIH-11359689 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21+ with problematic cannabis use and insomnia who are willing to participate in telemedicine sessions.
✕Less likely to help
Individuals without insomnia or those unwilling to engage in remote therapy may see limited or no benefit.
What this research studies
If you’re an adult who uses cannabis and struggles with insomnia, this study offers a telemedicine CBT-for-insomnia program tailored for cannabis users. The researchers will compare the sleep-focused therapy to standard sleep education delivered remotely, looking at changes in sleep and cannabis use over time. The study builds on previous findings that improving sleep can help people cut back on cannabis and feel better during daytime hours. Participation would involve remote sessions, sleep tracking, and assessments to understand how sleep regulation relates to cannabis use.
Why it matters
Potential benefit: If successful, participants may experience better sleep and reduced cannabis use, potentially easing related daytime impairment.
How similar studies have gone: Prior research suggests tailored CBT-i can improve sleep and reduce cannabis use, though this exact approach in heavy cannabis users is being tested.
Where this research is happening
-
University of Michigan at Ann Arbor
Ann Arbor, United States Active
Researchers
- Principal investigator: Arnedt, J. Todd — University of Michigan at Ann Arbor
- Study coordinator: Arnedt, J. Todd
Related research
Other NIH-funded projects on the same topics.
-
Helping adults with problematic cannabis use sleep better
This project explores how a special type of talk therapy for insomnia can help adults who use cannabis regularly to improve their sleep and reduce cannabis use.
-
Improving sleep to help adults reduce problematic cannabis use
This study is looking at how improving sleep with online therapy can help adults who have trouble sleeping and also use cannabis, aiming to make both their sleep and daily life better while reducing their cannabis use.
-
Hemp-derived CBD for reducing cannabis use in high-THC concentrate users
A randomized, placebo-controlled trial tests whether hemp-derived CBD can help adults who mainly use high-potency cannabis concentrates reduce their cannabis use.
-
Understanding how minority stress affects cannabis use in sexual minorities
A research project follows young adult sexual minorities to see how daily stress and coping help explain cannabis use and related problems.
-
Terminal cannabinoid CB1 receptor changes in schizophrenia and cannabis use
This grant studies how cannabis use and schizophrenia together affect a brain receptor (CB1) and what that could mean for memory and symptoms.
-
Cannabis policies and prenatal cannabis use: how laws affect moms and babies
This grant studies how changes in recreational cannabis laws influence cannabis use during pregnancy and health outcomes for mothers and children.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.